Loading provider…
Loading provider…
Infectious Disease Physician in Corona, CA
NPI: 1104921303HQ Phone
Get M.D. Fred's Phone Numberphone_androidMobile
Get M.D. Fred's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
1974 - 2026
PA State Medical License
1979 - 1984
CA State Medical License

American Board of Internal Medicine
Internal Medicine
Kaiser Permanente Southern California (Los Angeles)
Residency • Internal Medicine
1975 - 1976
Internship • Internal Medicine
1973 - 1974
University of Southern California/Los Angeles General Medical Center (USC/LA General)
Residency • Internal Medicine
1974 - 1975
Keck School of Medicine of USC
keck.usc.edu
Medical School
Until 1973
Empyema due to Streptococcus mutans
Authors: Sattler, F R, Ruskin, J
Journal: Chest
'Clindamycin and Primaquine Therapy for Mild-to-Moderate Episodes of Pneumocystis
Authors: Black, J R, Feinberg, J, Murphy, R L, Fass, R J, Finkelstein, D, Akil, B, Safrin, S, Carey, J T, Stansell, J, Plouffe, J F
Journal: Clin Infect Dis
Ascitic fluid and serum cefotaxime and desacetyl cefotaxime levels in patients
Authors: Bruce Runyon, J. Cohen
Journal: Dig Dis Sci
Lead Sponsor: University of California, San Diego
Collaborators: University of Southern California, University of California, San Francisco, PalmTree Clinical Research Inc.
Intervention / Treatment: DRUG: Tesamorelin
Lead Sponsor: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
Collaborators: National Institute of Allergy and Infectious Diseases (NIAID)
Intervention / Treatment: DRUG: Sofosbuvir/Velpatasvir (SOF/VEL), OTHER: Minimal Monitoring (MINMON) Strategy
Lead Sponsor: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
Collaborators: National Institute of Allergy and Infectious Diseases (NIAID), Exegi Pharma, LLC
Intervention / Treatment: DRUG: Placebo, DRUG: Visbiome Extra Strength